作者
Matthew A Rank, Rajiv N Sharaf, Glenn T Furuta, Seema S Aceves, Matthew Greenhawt, Jonathan M Spergel, Yngve T Falck-Ytter, Evan S Dellon, Karen A Chachu, Lukejohn Day, Benjamin Lebwohl, Thiruvengadam Muniraj, Amit Patel, Anne F Peery, Raj Shah, Harminder Singh, Siddharth Singh, Stuart J Spechler, Shahnaz Sultan, Grace L Su, Aaron P Thrift, Jennifer M Weiss, Adam V Weizman, Jonathan A Bernstein, Chitra Dinakar, David BK Golden, David A Khan, Jay Lieberman, John Oppenheimer, Marcus Shaker, David R Stukus, Dana V Wallace, Julie Wang
发表日期
2020/5/1
来源
Annals of Allergy, Asthma & Immunology
卷号
124
期号
5
页码范围
424-440. e17
出版商
Elsevier
简介
Eosinophilic esophagitis (EoE) is a chronic inflammatory condition of the esophagus. Many new studies have been reported recently that describe EoE management. An expert panel was convened by the American Gastroenterological Association Institute and the Joint Task Force on Allergy-Immunology Practice Parameters to provide a technical review to be used as the basis for an updated clinical guideline. This technical review was developed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework. Eighteen focused EoE management questions were considered, with 15 answered using the GRADE framework and 3 with a narrative summary. There is moderate certainty in the evidence that topical glucocorticosteroids effectively reduce esophageal eosinophil counts to <15 per high-power field over a short-term treatment period of 4–12 weeks, but very low …
引用总数